MS Views and News

MS Views and News
Click Logo - MS Views & News is Dedicated to Providing You with Multiple Sclerosis News and Information

Thursday, March 31, 2011

MS in the News: Gilenya,Tysabri and other treatments

If you are having trouble viewing this message, please Click Here

 Today is: March 31, 2011

THIS e-Newsletter is 
reaching people in (83) Countries 

 TOPICS this week include:
 Gilenya, Tysabri, Stem Cell News, Patient Stories
 and More

"Providing You with
'MS Views and News', 
IS What We Do" _______________________________


 WE are a NOT for Profit

MSV&N is a 501©(3) organization as recognized by the Internal Revenue Service. Your gift is tax deductible to the extent permitted by law.

  •        Every Dollar Counts

  •          Please click here 

  •   All Contibutions are Tax Deductible 

    Visit our Online Charity Auctions
    See below right
    for further 
    Avonex - 
    MS ActiveSource
    (800) 456-2255
    ---------------------Betaseron  -
    Betaplus MS
    (800) 788-1467
    Shared  Solutions
    (800) 887-8100
    Patient Support 
    (866) 925-2333
    Patient Support 
    (877) 408-4974
    Rebif  - 
    MS LifeLines
    (877) 447-3243  ---------------------
    Novantrone - 
    TOUCH  Program
    (800) 456-2255   
    Unless you really want to
    Unsubscribe from receiving
    our publications.
    Clicking the unsubscribe link
     will not allow you to get these
     e-newsletters or other
    information we provide.
    Find us on Facebook
    at our primary page: 
    For all affected by MSClick: 
    For Caregivers, 
    For the MS Patient with a progressive
     form of Multiple Sclerosis, Click:
    Find Stuart on Facebook
                                   VISIT OUR BLOG: 
                          "Stu's Views & MS News" 
                                     CLICK HERE

             This week's  (12) Postings 

    March 30, 2011
    Mar 30, 2011

    Potential New Treatment for Multiple Sclerosis
    Mar 29, 2011

    Report Identifies Cluster areas for MS in Ohio
    Mar 29, 2011

    The 'MS Views & News' - Online Charity Auction Series

    Novartis’s Gilenya MS Pill to Cost EU22,000 a Year in Germany
    Mar 26, 2011

    Sativex recommended for approval in six European countries to treat multiple sclerosis
    Mar 26, 2011

    Bellingham man with MS scales Mount Baker, helps others cope with the disease

    Visit our archived Podcasts (webcasts)
    By clicking:
    Visit our Online Charity Auctions
    regularly, and please bid. We always have a lot of wonderful things up for sale. 
    Maybe you will find something for yourself or, perhaps, a gift for someone else. 
    Take a look. Click: 
     Pass this email along to others, with your endorsement of
    SEE Patient and MS learning Videos 
    Scroll to the bottom of the page to see all the videos found there, for you to learn from. 

    Visit Our Blog, Bookmark the website and review each week's informational M.S. postings by Clicking here
    Facebook and Twitter 
    information and Website
    addresses (URL's)  
    TIME and Effort are put into each week's  e-newsletters and podcast series. 
    Please share the information we provide to educate and inform, with others. 

     Sponsorships for this e-Newsletter and our
    podcast series, are provided by:  
    OUR MISSION:  'MS Views and News' (MSVN)  is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis.  In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.

    -Newsletter Disclaimer:
    ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

    No comments:

    Post a Comment

    Leave comments only that directly pertain to each article.
    All solicitations will be removed.